Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek Morris

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Biological Psychiatry|May 22, 2012
Neurotrophic tyrosine kinase polymorphism impacts white matter connections in patients with major depressive disorderMelissa L Murphy, Angela Carballedo, Andrew J Fagan, et al.
Plos One|May 19, 2011
Genetic classification of populations using supervised learningMichael Bridges, Elizabeth A Heron, Colm O'Dushlaine, et al.
Schizophrenia Research|May 24, 2006
Are deficits in executive sub-processes simply reflecting more general cognitive decline in schizophrenia?Gary Donohoe, Sarah Clarke, Derek Morris, et al.
European Journal of Human Genetics : EJHG|June 24, 2010
Population structure and genome-wide patterns of variation in Ireland and BritainColm T O'Dushlaine, Derek Morris, Valentina Moskvina, et al.
Neuroscience Letters|September 25, 2007
D-amino acid oxidase (DAO) genotype and mood symptomatology in schizophreniaAiden Corvin, Gary Donohoe, Kevin McGhee, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 23, 2012
Effect of genetic variant in BICC1 on functional and structural brain changes in depressionRachel Bermingham, Angela Carballedo, Danuta Lisiecka, et al.
Psychological Medicine|March 3, 2026
Investigating the relationship between Toll-like receptor activity, low-grade inflammation, cognitive deficits, and antipsychotic drug dose in schizophrenia patients: a moderation analysisSaahithh Redddi Patlola, Brian Hallahan, Ross McManus, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 24, 2013
Brain-derived neurotrophic factor Val66Met polymorphism and early life adversity affect hippocampal volumeAngela Carballedo, Derek Morris, Peter Zill, et al.
Journal of the International Neuropsychological Society : JINS|October 27, 2006
Do antisaccade deficits in schizophrenia provide evidence of a specific inhibitory function?Gary Donohoe, Richard Reilly, Sarah Clarke, et al.
Adipocyte|September 6, 2017
Itm2a silencing rescues lamin A mediated inhibition of 3T3-L1 adipocyte differentiationStephanie J Davies, James Ryan, Patrick B F O'Connor, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Biological Psychiatry|May 22, 2012
Neurotrophic tyrosine kinase polymorphism impacts white matter connections in patients with major depressive disorderMelissa L Murphy, Angela Carballedo, Andrew J Fagan, et al.
Plos One|May 19, 2011
Genetic classification of populations using supervised learningMichael Bridges, Elizabeth A Heron, Colm O'Dushlaine, et al.
Schizophrenia Research|May 24, 2006
Are deficits in executive sub-processes simply reflecting more general cognitive decline in schizophrenia?Gary Donohoe, Sarah Clarke, Derek Morris, et al.
European Journal of Human Genetics : EJHG|June 24, 2010
Population structure and genome-wide patterns of variation in Ireland and BritainColm T O'Dushlaine, Derek Morris, Valentina Moskvina, et al.
Neuroscience Letters|September 25, 2007
D-amino acid oxidase (DAO) genotype and mood symptomatology in schizophreniaAiden Corvin, Gary Donohoe, Kevin McGhee, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 23, 2012
Effect of genetic variant in BICC1 on functional and structural brain changes in depressionRachel Bermingham, Angela Carballedo, Danuta Lisiecka, et al.
Psychological Medicine|March 3, 2026
Investigating the relationship between Toll-like receptor activity, low-grade inflammation, cognitive deficits, and antipsychotic drug dose in schizophrenia patients: a moderation analysisSaahithh Redddi Patlola, Brian Hallahan, Ross McManus, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 24, 2013
Brain-derived neurotrophic factor Val66Met polymorphism and early life adversity affect hippocampal volumeAngela Carballedo, Derek Morris, Peter Zill, et al.
Journal of the International Neuropsychological Society : JINS|October 27, 2006
Do antisaccade deficits in schizophrenia provide evidence of a specific inhibitory function?Gary Donohoe, Richard Reilly, Sarah Clarke, et al.
Adipocyte|September 6, 2017
Itm2a silencing rescues lamin A mediated inhibition of 3T3-L1 adipocyte differentiationStephanie J Davies, James Ryan, Patrick B F O'Connor, et al.
Pageof 6